
Über hema.to GmbH
hema.to is a Munich-based startup building CellStudio, AI-powered flow cytometry analysis software for cytometrists and hematologists. CellStudio takes labs from raw FCS file to finalized report in one workflow: data from the flow cytometer is uploaded automatically and anonymized, the AI predicts a cell type for every event, cases are flagged using WHO-based rules, and print-ready reports are generated in one click, while experts stay in control at every step. CellStudio has been validated across 5 lab sites and 20,000 patient samples, and hema.to is backed by investors including Heal Capital, Elaia, HTGF and Bayern Kapital.
Mehr davon





